A Randomised Controlled Trial of Tripterygium Wilfordii Polyglycoside in the Long-Term Treatment of Stage IV Diabetic Kidney Disease (DKD)
Drug Design, Development and Therapy · 2026-11 · Volume 20 · 1-21
DOI: 10.2147/dddt.s640159 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2026-11. Verfasst von Ban Zhao und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhao, B., Dang, X., Wang, Y., Li, T., Chen, A., Yang, L., & Mao, Y. (2026). A Randomised Controlled Trial of Tripterygium Wilfordii Polyglycoside in the Long-Term Treatment of Stage IV Diabetic Kidney Disease (DKD). Drug Design, Development and Therapy, Volume 20, 1-21. https://doi.org/10.2147/dddt.s640159
Vancouver
Zhao B, Dang X, Wang Y, Li T, Chen A, Yang L, et al. A Randomised Controlled Trial of Tripterygium Wilfordii Polyglycoside in the Long-Term Treatment of Stage IV Diabetic Kidney Disease (DKD). Drug Design, Development and Therapy. 2026;Volume 20:1-21. doi:10.2147/dddt.s640159
BibTeX
@article{Zhao2026,
author = {Zhao, Ban and Dang, Xin and Wang, Yuan and Li, Tianhui and Chen, Aiqun and Yang, Liping and Mao, Yonghui},
title = {A Randomised Controlled Trial of Tripterygium Wilfordii Polyglycoside in the Long-Term Treatment of Stage IV Diabetic Kidney Disease (DKD)},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--21},
doi = {10.2147/dddt.s640159}
}
EUVIMED